Pembrolizumab-based therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pembrolizumab-based therapy, covering 2022-12-27 to 2022-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas [Phase 2]